The global Protein Expression Market is expected to reach USD 3.0 billion by the year 2025 growing at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing demand for biologics and expansion of the biopharmaceutical industry have resulted in massive growth of the protein expression market. Rising demand for therapeutic proteins such as insulin, hormones, monoclonal antibodies and vaccines is a major factor that propels growth of the market during forecast period. Thus, many biotechnology and pharmaceuticals companies have begun to concentrate on the development and manufacturing of advanced therapeutic proteins for the treatment of severe chronic diseases such as cancer, hemophilia, infectious diseases, anemia, and multiple sclerosis.
Increasing
investment in the R&D, by biotechnology and pharmaceutical companies, is
another major factor supporting the sector growth. The availability of new and
advanced technologies to cater the needs of drugs & biologics product
manufacturers boosts the adoption of protein expression products for research
and manufacturing applications. In addition, several pharmaceutical and
biotechnology manufacturers are undergoing collaborations and partnerships to
achieve leadership in the sector. For instance, in December 2016, Takara Bio, Inc.
signed a merger agreement with Rubicon Genomics, Inc. to strengthen its
genomics business.
Browse
Details of Report @ http://www.grandviewresearch.com/industry-analysis/protein-expression-market
Further Key Findings From The Report Suggest:
- Prokaryotic
expression systems segment was the largest revenue-generating amongst
others owing to its large application in biologics and drug productions
- Mammalian
cell expression systems is the fastest growing segment of the protein
expression market owing to its growing demand for proteomics research and
biologics manufacturing
- Reagents
segment held the largest revenue share in the market, which is attributed
to its repetitive purchase fortherapeutic, industrial, and research
applications
- The services
segment is projected to grow at highest rate due to increasing trend of
outsourcing of protein expression services by research labs and drug
manufacturers
- Therapeutic
application segment was leading in 2016, due to high demand of therapeutic
proteins for the treatment of cancer, infectious diseases, anemia,
hemophilia, and multiple sclerosis
- The
pharmaceutical and biotechnological companies segment dominated the sector
in terms of revenue in 2016 due to rising focus on proteomics research and
increasing production of biologics products
- North
America was the leading regional market in 2016 and is expected to
maintain its dominance during the forecast period, because of the presence
of large number of biopharmaceutical and biotechnology companies in this
region
- The Asia
Pacific region is projected to grow at a highest CAGR during the forecast
period owing to untapped opportunities in the developing countries
including China and India
- Some of the
major players include Agilent Technologies, Inc., Bio-Rad Laboratories,
Inc., Thermo Fisher Scientific Inc., Merck KGaA, New England Biolabs,
Promega Corporation, Qiagen, and Takara Bio, Inc.
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist,
USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment